Exai Bio is a next-generation liquid biopsy company. Exai Bio's proprietary RNA and artificial intelligence-based liquid biopsy platform delivers clinical insights into cancer biology to enable the earliest, most accurate diagnosis of cancer.

Palo Alto, CA, USA

Exai Bio

The Blue Venture Fund is a corporate venture fund program to which thirty-six BCBS entities have committed over $800 million across four Funds. The Funds invest in promising emerging companies of strategic relevance to Blue Cross and/or Blue Shield Plans and provide access to its portfolio to deploy innovation at scale. The Blue Venture Fund is sponsored by the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield companies.

Blue Venture Fund

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Hello,
In 5 quick steps, tell us about the type of opportunity you'd be interested in next. We'll use this information to help connect you to relevant opportunities in the BCBS Venture Partners network as they come up. You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a BCBS Venture Partners company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Companies you'll love to work for